Home / About Us / News

Geistlich launches new collagen membrane at the IOS

At the International Osteology Symposium (IOS) in Vienna, Geistlich launched the advanced collagen membrane Geistlich Bio-Gide® Forte for the European market. The launch is part of the company’s global portfolio expansion, which includes new technologies, strategic partnerships, and targeted acquisitions. At the same time, Geistlich is expanding its initiatives to support the next generation.
April 27, 2026

This year’s International Osteology Symposium was dedicated to Geistlich’s 175th anniversary. This milestone year marks the company’s expansion into new fields of regenerative medicine and the launch of 20 new products in over 40 countries. Among them is the advanced collagen membrane Geistlich Bio-Gide® Forte. Following its successful introduction in the United States and highly positive feedback from clinical practice, it is now also available in Europe. Geistlich Bio-Gide® Forte builds on proven Geistlich technology and offers increased strength, improved stability, and easy handling. The membrane’s strength was demonstrated in a load test at the IOS: 1,445 studies document the performance of the Geistlich Bio-Gide® technology, a scientific foundation of evidence equivalent to around 4 kilograms of paper, which Geistlich Bio-Gide® Forte can hold. 

Tradition and expertise 
At the IOS booth, visitors were able to immerse themselves in Geistlich’s rich history. What began in 1851 as Switzerland’s first glue factory evolved into a pioneer in medical regeneration thanks to scientific curiosity and expertise in bone and tissue processing. “As a Swiss family-owned regenerative technology company, responsibility and pioneering spirit is in our DNA. Our pioneering spirit will drive continuous innovation. And, responsibility for patients, for our partners, for science and for quality,” says CEO Diego Gabathuler.  

Promoting young talent 
To support the next generation, Geistlich has launched two additional development programs. With the “Next Generation Round Table,” a total of 67 selected, talented clinicians aged 30 to 42 from around the world will begin a three-year training program this year. In addition, the “Rising Stars Case Competition” recognized outstanding achievements in clinical practice on the IOS stage, such as Viraj Patel (UK) on the use of Allodyn® with and without REGENFAST® in a split-mouth comparison, Lorenzo Fiscalini (Switzerland) on the integration of Yxoss CBR® and REGENFAST® in bone regeneration in the anterior region, and Roberto Ledergerber (Ecuador) on innovative approaches to tooth splitting and periodontal regeneration.